Yoga Vidya International

Community on Yoga, Meditation, Ayurveda and Spirituality

Indian Council of Medical Research Chief Validates Low-Dose-HCQ-For-Covid19-Patients Theory of Dr. Swaamee Aprtemaanandaa Jee

Dr. Swaamee Aprtemaanandaa Jee has propounded the theory of Low Doses of Hydroxychloroquine as a Safer therapy for Covid-19 patients, in his research paper titled "Know the Correct Doses of Hydroxychloroquine And Zinc Tablets for C... published on 26th of May, 2020.
In the above referred to research paper, Dr. Swaamee Aprtemaanandaa Jee has theorized that the only low doses of Hydroxychloroquine given as a therapy are safe for Covid-19 patients. He said the daily doses of 50-100 mg only are safe and not 200 mg - 400 mg.
The Indian Council of Medical Research (ICMR) Chief Balram Bhargava has now validated Dr. Swaamee Aprtemaanandaa Jee's theory by telling mass media outlets that the observational data and controlled studies in India have shown HCQ to be a safer therapy even in high risk-groups because it is being given in low doses compared to high doses being given by the World Health Organisation (WHO) and other countries. For example, he said, Covid-19 patient in India is given two 400 mg tablets of HCQ in the beginning followed by one dose of a 400 mg of the same every week continuously for the succeeding weeks. He added, also that the HCQ is safer than Chloroquine. 
Obviously, this Indian dose is quite low compared to the high doses of 200 mg - 400 mg - 800 mg being given continuously for several days or weeks to Covid-19 patients in non-Indian hospitals.
According to Dr. Swaamee Aprtemaanandaa Jee, Indians generally have a higher immunity-quotient than Europeans and Americans. Also, their Toletance-thrashold for antibiotics and antiviral drugs is higher than these two aforesaid groups of people. That's why the dose of 400 mg has been found by ICMR as safe even in high risk-groups. The 400 mg dose is 'Low' in the Indian context. But, it's high in European and American contexts. That's Dr. Swaamee Aprtemaanandaa Jee has come to the conclusion and proposed in his earlier research paper the doses of 50-100 mg with varying time-periods.
To set the matter straight and clear, he says the following doses are safe for different groups of Covid-19 patients in European and American geographies:
(1) Those with Mild Symptoms be given a daily dose of 50 mg of HCQ + 5 mg of Zinc supplement twice a day continuously for 7 days. Examine their SGOT and Corona-19 Viral-Load reports on the 8th day to decide further course of medication.
(2) Those with Moderate Symptoms be given a daily dose of 100 mg of HCQ + 5 mg of Zinc supplement twice a day for three days followed by an examination of their SGOT and Corona-19 Viral-Load report on the 4th day to decide further course of medication.
(3) Those with Serious/Heavy Symptoms be given a daily dose of 150 mg of HCQ + 5 mg of Zinc supplement twice a day for three days followed by an examination of their SGOT and Corona-19 Viral-Load report on the 4th day to decide the course of medication.

Of course, some approved safe antiinflammatory drug and Anticoagulant must be administered to all Covid-19 patients in the aforesaid three scenarios, also. 
(4) In the cases of Diabetic patients, Heart patients and Hypersensitivity patients; and elderly people (60+ age group) either avoid HCQ completely and give them standard care/support + other harmless antiviral drugs and their regular treatment/medication (for diabetes and cardio Rhythm problems) or If at all you wish to take the risk because such a Covid-19 diabetic/Heart patient is just going to die, you may as a last resort administer them 100 mg HCQ tablet daily for three continuous days. Examine their SGOT and Corona-19 Viral-Load reports on the 4th day to decide further course of medication.
You may make adjustments in quantities of HCQ and Zinc supplementation, allowing for differences in age-group of patients. For example, give lower doses to elderly people compared to higher doses to younger lot. Ultimately, you as a Medical Doctor have to use your own profound Uncommon-Common Sense and Clinical Observations to decide the Unique course of medication for each Covid-19 patient since each of them has a Unique set of age, underlying health conditions, Tolerance-Thresholds and Immunity-quotient...!
- Dr. Swaamee Aprtemaanandaa Jee
(The writer is a Scientific Healer, yoga-Practitioner, Research Scientist, Epidemiologist, citizen-Economist, and well known for informative analytical pieces on Healing, Spirituality, Yoga, Fitness, Health, Medicine, Ayurveda, Science, Economics, and Politics)

(Fotos: Courtesy of HENDRIK SCHMIDT/AFP, THE TIMES OF INDIA 

Views: 15

Tags: Balram, Bhargava, COVID19, Cardio, Council, Diabetes, HCQ, Health, Hydroxychloroquine, ICMR, More…Immunity-quotient, Indian, Medical, Organisation, Research, Rhythm, Tolerance-, WHO, World, medications, of, research, threshold

Comment

You need to be a member of Yoga Vidya International to add comments!

Join Yoga Vidya International

© 2020   Yoga Vidya | Contact | Privacy Policy |   Powered by

Badges  |  Report an Issue  |  Terms of Service